Michael Landsittel, Chief Financial Officer at Blueprint Medicines Corp (BPMC), sold 2,918 shares at $86.61 ($253K) on 2021-03-04, disclosed to the SEC on 2021-03-05.
Open-market sale of $253k BPMC by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.61 | 1,411 | $122K | 48.3% |
| 2 | $86.61 | 1,411 | $122K | 48.3% |
| 3 | $88.98 | 96 | $9K | 3.4% |
| Total | $86.69 avg | 2,918 | $253K | 100% |
| Filing → |
| BPMC | SELL | 2024-05-17 | $824K | — | Filing → |
| BPMC | SELL | 2024-05-06 | $1.1M | — | Filing → |
| BPMC | SELL | 2024-04-01 | $475K | — | Filing → |